Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure-Reference-Cited by-同舟云学术

Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure

Published:2020-05-03 Issue:7 Volume:16 Page:641-644
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Young Megan K¹²,Ng Shu-Kay¹,Nimmo Graeme R¹³,Cripps Allan W¹

Affiliation:

1. School of Medicine and Menzies Health Institute – Queensland, Griffith University, Southport, Australia

2. Metro North Public Health Unit, Metro North Hospital and Health Service, Brisbane, Australia

3. Pathology Queensland, Queensland Health, Brisbane, Australia

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1763303

Reference19 articles.

1. Immunoglobulins for preventing hepatitis A

2. Australian Government Department of Health. Overweight and obesity Canberra: Australian government department of health; 2019 [updated 19 Jun 2019; cited 2019 Jun 2019]. Available from: https://www.health.gov.au/internet/main/publishing.nsf/Content/Overweight-and-Obesity

3. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles

4. Immune markers and correlates of protection for vaccine induced immune responses

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Anti‐Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight‐Based Dosing of Polyvalent Immunoglobulin;The Journal of Clinical Pharmacology;2024-07-05

2. Climate Change Implications for Tidal Marshes and Food Web Linkages to Estuarine and Coastal Nekton;Estuaries and Coasts;2021-01-21